Lotus Launches In Europe: Boston Scientific Joins Crowded TAVR Field
This article was originally published in The Gray Sheet
Executive Summary
The firm announced the CE mark and European launch of its transcatheter aortic heart valve replacement device Oct. 28. Boston is one of at least seven firms with a TAVR device now on the market in Europe.
You may also be interested in...
Edwards' TAVR Platforms Challenged In Boston Scientific Patent Suits
More patent litigation is emerging in the transcatheter aortic valve replacement space with two recent lawsuits alleging that Edwards Lifesciences' Sapien 3 TAVR device and delivery systems violated a total of nine patents held by Boston Scientific.
EuroPCR In Brief
Device trial data at the EuroPCR 2015 conference, held in Paris May 19-22, featured presentations on TAVR, stents and drug-coated balloons.
Medtronic’s CoreValve Evolut R “Recapturable” TAVR Earns CE Mark
The next-generation version of the CoreValve transcatheter aortic valve can be repositioned during the implant procedure.